Citadel Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Sell
581,187
-285,031
-33% -$961K ﹤0.01% 6076
2025
Q4
$2.45M Sell
866,218
-248,372
-22% -$1.28M ﹤0.01% 5545
2025
Q3
$7.76M Buy
1,114,590
+951,558
+584% +$6.71M ﹤0.01% 3624
2025
Q2
$965K Sell
163,032
-414,728
-72% -$2.39M ﹤0.01% 7184
2025
Q1
$3.69M Sell
577,760
-46,470
-7% -$448K ﹤0.01% 4397
2024
Q4
$7.42M Buy
624,230
+226,445
+57% +$3.86M ﹤0.01% 3361
2024
Q3
$11M Sell
397,785
-232,771
-37% -$5.82M ﹤0.01% 2753
2024
Q2
$15M Buy
630,556
+578,280
+1,106% +$13.6M ﹤0.01% 2313
2024
Q1
$920K Sell
52,276
-222,777
-81% -$3.28M ﹤0.01% 7091
2023
Q4
$4.34M Sell
275,053
-392,776
-59% -$4.06M ﹤0.01% 4011
2023
Q3
$5.74M Buy
667,829
+238,171
+55% +$1.69M ﹤0.01% 3440
2023
Q2
$3.39M Sell
429,658
-255,861
-37% -$1.78M ﹤0.01% 4253
2023
Q1
$5.11M Buy
685,519
+447,452
+188% +$4.45M ﹤0.01% 3777
2022
Q4
$2.81M Buy
238,067
+137,567
+137% +$1.57M ﹤0.01% 4857
2022
Q3
$927K Buy
100,500
+44,911
+81% +$544K ﹤0.01% 7165
2022
Q2
$549K Sell
55,589
-136,249
-71% -$2.75M ﹤0.01% 8434
2022
Q1
$6.61M Buy
191,838
+69,155
+56% +$2.24M ﹤0.01% 3642
2021
Q4
$6.11M Buy
122,683
+77,668
+173% +$4.09M ﹤0.01% 3942
2021
Q3
$2.07M Buy
45,015
+13,937
+45% +$552K ﹤0.01% 6262
2021
Q2
$930K Sell
31,078
-18,121
-37% -$370K ﹤0.01% 8551
2021
Q1
$1M Buy
49,199
+26,404
+116% +$557K ﹤0.01% 8109
2020
Q4
$380K Buy
+22,795
New +$300K ﹤0.01% 8655
2020
Q2
Sell
-17,273
Closed -$106K 9738
2020
Q1
$106K Buy
+17,273
New +$140K ﹤0.01% 8593
2017
Q2
Sell
-10,428
Closed -$43K 7446
2017
Q1
$43K Buy
+10,428
New +$44.4K ﹤0.01% 7076
2016
Q1
Sell
-38,659
Closed -$235K 6735
2015
Q4
$235K Buy
+38,659
New +$268K ﹤0.01% 5576

Other funds holding ASPN

Citadel Advisors's ASPN Position: Q1 2026 in Review

Citadel Advisors reduced its Aspen Aerogels (ASPN) stake by 33% in Q1 2026, selling an estimated $961K and leaving 581,187 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6076.

Citadel Advisors first reported a position in ASPN in Q4 2015 and has held it in 25 quarters since. The position peaked at $15M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Citadel Advisors held 581,187 shares of Aspen Aerogels worth $1.99M as of Q1 2026.
  • Citadel Advisors sold 285,031 Aspen Aerogels shares in Q1 2026, an estimated $961K.
  • Aspen Aerogels made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6076 holding.
  • Citadel Advisors first reported a position in Aspen Aerogels in Q4 2015 and has held it in 25 quarters since.
  • Citadel Advisors's Aspen Aerogels position peaked at $15M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.